Abstract:Background and objectives Glomerular IgM deposition is commonly shown in primary FSGS and sometimes accompanied by C3 deposition. Clinical presentation and treatment outcomes of these patients are not investigated in detail.Design, setting, participants, &measurements One hundred six consecutive patients with biopsy-proven primary FSGS from 2004 to 2014 were enrolled retrospectively. Clinical features and treatment outcomes were compared between patients with and without IgM/C3 deposition.Results Fifty-eight (54.7%) patients presented with IgM glomerular deposition on sclerotic segments. C3 and C1q depositions were shown exclusively in patients with IgM deposition (34.5% versus 0.0%; P<0.001 and 8.6% versus 0.0%; P=0.04, respectively). Patients with IgM deposition were younger (median; range: 24.5; 18.8-39.0 versus 46.5; 26.0-64.0 years old; P=0.001), had higher level of serum IgM (142.5; 96.3-206.0 versus 107.0; 71.0-140.0 mg/dl; P=0.01), and had higher level of eGFR (median; range 97.7; 48.0-135.8 versus 62.1; 33.7-93.9 ml/min per 1.73 m(2); P=0.01) at the time of kidney biopsy. The percentage of sclerosis lesions was significantly higher in patients with C3 deposition (median; range: 21.7%; 15.3%-31.1% versus 9.2%; 6.6%-20.0%; P=0.002). Although patients received comparable immunosuppressive treatments during 58.9 (29.5-81.1) months of follow-up, a significantly higher prevalence of refractory cases (no response or steroid dependent) occurred in patients with combined IgM and C3 deposition compared with patients with IgM deposition alone or without IgM deposition (58.8% versus 22.2% versus 15.6%, respectively; P=0.004). Multivariate analysis identified combined IgM and C3 deposition (odds ratio, 11.32; 95% confidence interval, 2.26 to 56.65; P=0.003) as an independent risk factor for refractory patients; 19 of 98 patients developed renal dysfunction when their serum creatinine levels increased >30% from baseline and reached >1.5 mg/dl. Combined IgM and C3 deposition (hazard ratio, 5.67; 95% confidence interval, 1.34 to 23.84; P=0.02) was identified as an independent risk factor for renal dysfunction.Conclusions Patients with primary FSGS and IgM and C3 deposition showed unfavorable therapeutic responses and worse renal outcomes, which indicate that IgM and C3 deposition might involve disease progression via complement activation.

Glomerular Complement Factor H–Related Protein 5 is Associated with Histologic Injury in Immunoglobulin A Nephropathy

Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.

Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy

Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment

Levels of Urinary Complement Factor H in Patients with IgA Nephropathy Are Closely Associated with Disease Activity

Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin-Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H-Related Protein-5 (FHR5) Deposition

The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides with Glomerular IgA Deposition

Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy

Implication of Urinary Complement Factor H in the Progression of Immunoglobulin A Nephropathy

Severe Glomerular C3 Deposition Indicates Severe Renal Lesions and a Poor Prognosis in Patients with Immunoglobulin A Nephropathy

The clinicopathologic characteristics of Immunoglobulin A nephropathy related to C3 deposits

Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy

IgG Deposits in the Mesangium and Capillary Loops Predict Poor Renal Outcome in Patients with IgA Nephropathy: a Single-Center Retrospective Study

Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis.

Overactivation of the complement system may be involved in intrarenal arteriolar lesions in IgA nephropathy

The Clinical and Pathological Effects of Serum C3 Level and Mesangial C3 Intensity in Patients with IgA Nephropathy

Clinical Significance of Igm and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis

Glomerular IgG deposition predicts kidney disease progression in IgA nephropathy

Clinical relevance of glomerular C4d deposition in children with early IgA nephropathy or Henoch-Schönlein purpura nephropathy

Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN

C5a enhances Vδ1 T cells recruitment via the CCL2-CCR2 axis in IgA nephropathy